Sign in
4

Changes in Ownership

PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-029104

Chief Technology Officer sold 75,000 shares at an average $14.96 ($1,121,750)

  • Chief Technology Officer acquired 75,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

UECKER DARRIN · Chief Technology Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-11 Exercise or conversion : show line 1 in the form 10b5-1 +25,000 $4.00 $100,000 147,872 D
2025-09-11 Sale : show line 2 in the form 10b5-1 −25,000 $14.78 $369,500 122,872 D
2025-09-12 Exercise or conversion : show line 3 in the form 10b5-1 +25,000 $4.00 $100,000 147,872 D
2025-09-12 Sale : show line 4 in the form 10b5-1 −25,000 $14.32 $358,000 122,872 D
2025-09-15 Exercise or conversion : show line 5 in the form 10b5-1 +25,000 $4.00 $100,000 147,872 D
2025-09-15 Sale : show line 6 in the form 10b5-1 −25,000 $15.77 $394,250 122,872 D
Open-market sales · 75,000 sh · avg $14.96 · $1,121,750

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-09-11 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −25,000 156,534 D
2025-09-12 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −25,000 131,534 D
2025-09-15 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −25,000 106,534 D
Loading xslF345X05/rdgdoc.xml…